These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 21460325)
1. Assessments of HIV drug resistance mutations in resource-limited settings. Jordan MR Clin Infect Dis; 2011 Apr; 52(8):1058-60. PubMed ID: 21460325 [No Abstract] [Full Text] [Related]
2. Update of the drug resistance mutations in HIV-1: December 2009. Johnson VA; Brun-Vezinet F; Clotet B; Gunthard HF; Kuritzkes DR; Pillay D; Schapiro JM; Richman DD Top HIV Med; 2009 Dec; 17(5):138-45. PubMed ID: 20068260 [No Abstract] [Full Text] [Related]
3. Slow accumulation of HIV resistance mutations: implications for resource-limited settings? Stevens WS J Infect Dis; 2009 Sep; 200(5):670-2. PubMed ID: 19604045 [No Abstract] [Full Text] [Related]
4. HIV-1 drug resistance in variants from the female genital tract and plasma. Kemal KS; Burger H; Mayers D; Anastos K; Foley B; Kitchen C; Huggins P; Schroeder T; Picchio G; Back S; Gao W; Meyer WA; Weiser B J Infect Dis; 2007 Feb; 195(4):535-45. PubMed ID: 17230413 [TBL] [Abstract][Full Text] [Related]
5. Optimized protocol for detection of HIV-1 drug mutations in patients with low viral load. Stelzl E; Troppan KT; Winkler M; Korn K; Kessler HH J Virol Methods; 2010 Sep; 168(1-2):152-4. PubMed ID: 20471425 [TBL] [Abstract][Full Text] [Related]
6. HIV drug resistance tests: an update on methods for calculating phenotypic fold change from a viral genotype. Bellosillo NA; Bacheler L; Villacian J Clin Infect Dis; 2009 Mar; 48(5):687; author reply 687. PubMed ID: 19191661 [No Abstract] [Full Text] [Related]
7. [Prevalence of antiretroviral drug genotypic resistance among HIV patients in Cuenca, Spain]. Rodriguez-Escudero MJ; Prada de Medio E; Rosa Herranz C; Martinez Medina MC; Franquelo Gutierrez R Rev Esp Quimioter; 2007 Jun; 20(2):203-5. PubMed ID: 17893756 [TBL] [Abstract][Full Text] [Related]
8. Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: results from the DREAM programme. Bellocchi MC; Forbici F; Palombi L; Gori C; Coelho E; Svicher V; D'Arrigo R; Emberti-Gialloreti L; Ceffa S; Erba F; Marazzi MC; Silberstein FC; Perno CF J Med Virol; 2005 Aug; 76(4):452-8. PubMed ID: 15977236 [TBL] [Abstract][Full Text] [Related]
9. Low-frequency HIV-1 drug resistance mutations can be clinically significant but must be interpreted with caution. Johnson JA; Geretti AM J Antimicrob Chemother; 2010 Jul; 65(7):1322-6. PubMed ID: 20466851 [TBL] [Abstract][Full Text] [Related]
10. HIV-1 integrase variability and relationship with drug resistance in antiretroviral-naive and -experienced patients with different HIV-1 subtypes. Reigadas S; Marcelin AG; Houssaïni A; Yerly S; Descamps D; Plantier JC; Ruffault A; Amiel C; Trabaud MA; Flandre P; Fleury H; Masquelier B; J Antimicrob Chemother; 2013 Apr; 68(4):969-72. PubMed ID: 23184711 [No Abstract] [Full Text] [Related]
11. Update of the Drug Resistance Mutations in HIV-1. Johnson VA; Brun-Vezinet F; Clotet B; Gunthard HF; Kuritzkes DR; Pillay D; Schapiro JM; Richman DD Top HIV Med; 2008 Dec; 16(5):138-45. PubMed ID: 19106428 [TBL] [Abstract][Full Text] [Related]
12. 2011 update of the drug resistance mutations in HIV-1. Johnson VA; Calvez V; Günthard HF; Paredes R; Pillay D; Shafer R; Wensing AM; Richman DD Top Antivir Med; 2011 Nov; 19(4):156-64. PubMed ID: 22156218 [TBL] [Abstract][Full Text] [Related]
16. Description of two commercially available assays for genotyping of HIV-1. Stürmer M; Reinheimer C Intervirology; 2012; 55(2):134-7. PubMed ID: 22286883 [TBL] [Abstract][Full Text] [Related]
17. Update of the drug resistance mutations in HIV-1: 2007. Johnson VA; Brun-Vézinet F; Clotet B; Günthard HF; Kuritzkes DR; Pillay D; Schapiro JM; Richman DD Top HIV Med; 2007; 15(4):119-25. PubMed ID: 17720996 [No Abstract] [Full Text] [Related]
18. When do minority drug-resistant HIV-1 variants have a major clinical impact? Heneine W J Infect Dis; 2010 Mar; 201(5):647-9. PubMed ID: 20102273 [No Abstract] [Full Text] [Related]
19. HIV-1 genotypic drug-resistance interpretation algorithms need to include hypersusceptibility-associated mutations. Wang K; Samudrala R; Mittler JE J Infect Dis; 2004 Dec; 190(11):2055-6; author reply 2056. PubMed ID: 15529272 [No Abstract] [Full Text] [Related]
20. Implementation of an Italian multicentric care network for early HIV infection diagnosis: 1999-2001 report. Capiluppi B; Saracco A; Gianotti N; Mussini C; Butini L; Tomasoni L; De Gennaro M; Rizzolo L; Monolo G; Cargnel A; Moioli C; Arici C; Portelli V; Rizzardini G; Lazzarin A; Tambussi G J Biol Regul Homeost Agents; 2002; 16(1):73-8. PubMed ID: 12003179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]